Mendelspod Podcast
The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
- Update frequency
- every 5 days
- Average duration
- 27 minutes
- Episodes
- 503
- Years Active
- 2014 - 2025
5-Base Sequencing: Jonas Korlach and Tomi Pastinen
Pacific Biosciences has introduced a new method for detecting DNA methylation simultaneously with DNA sequencing. They are calling it 5-base sequencing.
Today on the program, Jonas Korlach, PacBio’s …
Today on the program, Jonas Korlach, PacBio’s …
00:30:03 |
Wed 25 May 2022
More Cancer Patients Die from Infections than Cancer, Says Alec Ford, CEO of Karius
Alec Ford is passionate about his message. No wonder. There's an astounding fact in cancer medicine that is little known and could make a big difference. More cancer patients are dying from infect…
00:37:08 |
Wed 18 May 2022
Some of the Lowest Hanging Fruits in Precision Medicine: Michelle Whirl-Carrillo on Pharmacogenomics
One of the underrated but true successes of precision medicine has been pharmacogenomics. Beginning in the ’90s with the approval of the drug Herceptin for HER2 positive breast cancer, tailoring dr…
00:31:22 |
Tue 10 May 2022
John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
Today we talk with John Nelson, Senior Principal Scientist at GE Research and veteran in the field of DNA synthesis. On January 7th, 2020, two weeks before the first cases of the coronavirus were re…
00:37:14 |
Thu 14 Apr 2022
A New Generation Comfortable Doing a Thousand Things at a Time Is Reinventing Life Science Says Joe Beechem of NanoString
“I’ve seen a lot of revolutions. Now we’re at the beginning of spatial biology, and I think it has the chance to transform life science similar to next gen sequencing, but even more. It’s going to …
00:39:29 |
Thu 07 Apr 2022
Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.
Are we now entering the age of proteomics the way we did with genomics thirty years ago?
We were told we should talk to today’s guest by four people in one week. He’s Omid Farokhzad, CEO and Founder …
We were told we should talk to today’s guest by four people in one week. He’s Omid Farokhzad, CEO and Founder …
00:45:22 |
Thu 31 Mar 2022
The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae
"There's an entire field of fragmentomics with a whole lot of people working on it. The DNA which is shed into the bloodstream has a certain length. The length of ctDNA is shorter than cfDNA, and …
00:35:17 |
Thu 17 Mar 2022
The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script
The DNA synthesis space is seeing some real creativity and disruption this past year. One newcomer, in particular, is shaking things up.
Sylvain Gariel is the co-founder and chief operating officer o…
Sylvain Gariel is the co-founder and chief operating officer o…
00:28:08 |
Thu 03 Mar 2022
Akoya Biosciences Launches New Integrated Spatial Platform: Our First Interview with CEO Brian McKelligon
Even though Brian McKelligon calls himself a rookie CEO, he comes to the top position at Akoya Biosciences with a veteran’s resume. His path to one of spatial biology’s hottest companies in 2022 wo…
00:30:25 |
Thu 24 Feb 2022
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
Harlan Robins is the Chief Scientific Officer at Adaptive Biotechnologies in Seattle. In 2014, Harlan and his brother Chad co-founded Adaptive as a spinout from the Fred Hutchinson Cancer Center whe…
00:31:11 |
Wed 16 Feb 2022
Twist Bioscience: A New Kind of DNA Synthesis Company
“DNA is changing everything for the better,” says today’s guest, Emily Leproust, CEO of Twist Bioscience. Twist has emerged at the heart of what a New York Times Magazine write-up recently headlined …
00:39:15 |
Thu 10 Feb 2022
Going High Resolution with 10X Genomics: Michael Schnall-Levin
Working at the Broad Institute early in his career, Michael Schnall Levin was discovering he was a biologist at heart. He’d begun his studies in physics then done his PhD in mathematics. But he'd w…
00:37:33 |
Thu 27 Jan 2022
George Church and Ben Lamm on the Launch of Colossal Biosciences
According to scientists, 30,000 species per year are going extinct. That’s 6 an hour, 150 per day. Up to one half of all species could be extinct by 2050.
This is a public episode. If you'd like to…
This is a public episode. If you'd like to…
00:41:08 |
Thu 20 Jan 2022
We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years
Chris Mason is back on the program for our end-of-year special. He’s Professor of Genomics, Physiology, and Biophysics at Weill Cornell School of Medicine and the author of such an outstanding book t…
00:47:10 |
Tue 21 Dec 2021
Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership
In a joint interview, Sean George, CEO of diagnostics firm, Invitae, and Christian Henry, CEO of sequencing tools company, Pacific Biosciences, say that “it was clear in the first five minutes of a p…
00:52:34 |
Tue 07 Dec 2021
Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director
There are some technologies that become so ubiquitous in biomedical research that their name turns synonymous with their use. This has been the case for the Luminex xMAP platform and multiple biomar…
00:23:28 |
Tue 30 Nov 2021
DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO
DNA is a multibillion-dollar industry in 2021 and satisfies many life science applications, including drugs, reagents, siRNA, PCR, diagnostics, synthetic biology, and many others. Enzymatic DNA synt…
00:28:31 |
Wed 17 Nov 2021
Tumor Evolution in Context with Christina Curtis
If one was going to be a cancer researcher, surely one would want to be Christina Curtis. She’s an associate professor of oncology and genetics at Stanford, and she studies tumor evolution. She’s t…
00:29:28 |
Thu 11 Nov 2021
The History of mRNA Vaccines with Elie Dolgin
"Scientists have been putting RNA into cells through a lipid delivery system for 44 years,” says Elie Dolgin. “And that’s ultimately the vaccine that has gone into millions of arms.”
Elie is the autho…
Elie is the autho…
00:44:37 |
Thu 04 Nov 2021
Hundreds of Thousands of Biological Molecules Undiscovered in Plant Chemical Space Says Founder of New Drug Discovery Company
“Why do plants make a host of chemicals they don’t use? One answer that has always intrigued me is that, unlike us, they can’t walk up and walk away from an environment they don’t like. Evolution h…
00:29:31 |
Tue 02 Nov 2021
Disclaimer: The podcast and artwork embedded on this page are the property of Theral Timpson. This content is not affiliated with or endorsed by eachpod.com.